AI assistant
Sending…
Bone Biologics Corp — Director's Dealing 2023
Mar 8, 2023
35440_dirs_2023-03-08_bc614923-0fd6-4584-977a-159a3ff4833f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2023-01-25
Reporting Person: Walsh Deina H (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-25 | Employee Stock Option | $0.24 | A | 18875 | Acquired | 2025-01-25 | Common Stock (18875) | Direct |
More from Bone Biologics Corp
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Mar 2
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 21
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Nov 7
Regulatory Filings
2025
Sep 26
Regulatory Filings
2025
Sep 4
Regulatory Filings
2025
Aug 29